[1] |
KULIK L, EI-SERAG HB. Epidemiology and management of hepatocellular carcinoma[J]. Gastroenterology, 2019, 156(2): 477-491. e1. http://www.sciencedirect.com/science/article/pii/S0891552010000590
|
[2] |
WILSON GC, GELLER DA. Evolving surgical options for hepatocellular carcinoma[J]. Surg Oncol Clin N Am, 2019, 28(4): 645-661. DOI: 10.1016/j.soc.2019.06.006.
|
[3] |
GAO H, WEN SJ, ZHANG X, et al. Preoperative risk factor analysis and prediction model establishment of microvascular invasion in small hepatocellular carcinoma[J]. Chin J Gen Surg, 2019, 34(11): 921-924. DOI: 10.3670.cma.j.issn.1007-631X.2019.11.003.
高航, 翁山耕, 张翔, 等. 小肝癌合并微血管侵犯的术前危险因素分析及预测模型构建[J]. 中华普通外科杂志, 2019, 34(11): 921-924. DOI: 10.3670.cma.j.issn.1007-631X.2019.11.003.
|
[4] |
TIWARI A, MUKHERJEE B, DIXIT M. MicroRNA key to angiogenesis regulation: MiRNA biology and therapy[J]. Curr Cancer Drug Targets, 2018, 18(3): 266-277. DOI: 10.2174/1568009617666170630142725.
|
[5] |
LIU C, SONG Z. Relationship between microRNA-21 and TLRs/NF-κB signaling pathway in peripheral blood mononuclear cells of rats with hepatocellular carcinoma[J]. Chin Hepatol, 2018, 23(2): 162-164. DOI: 10.3969/j.issn.1008-1704.2018.02.020.
刘驰, 宋展. 肝癌大鼠癌组织microRNA-21与外周血单个核细胞TLRs/NF-κB信号通路的关系[J]. 肝脏, 2018, 23(2): 162-164. DOI: 10.3969/j.issn.1008-1704.2018.02.020.
|
[6] |
Liver cancer committee of China Anti Cancer Association, Hepatology group of Hepatology branch of Chinese Medical Association, Pathology Committee of China Anti Cancer Association, et al. Evidence-based practice guidelines for the standardized pathological diagnosis of primary liver cancer in China (2015 update)[J]. J Clin Hepatol, 2015, 31(6): 833-839. DOI: 10.3969/j.issn.1001-5256.2015.06.004.
中国抗癌协会肝癌专业委员会, 中华医学会肝病学分会肝癌学组, 中国抗癌协会病理专业委员会, 等. 原发性肝癌规范化病理诊断指南(2015年版)[J]. 临床肝胆病杂志, 2015, 31(6): 833-839. DOI: 10.3969/j.issn.1001-5256.2015.06.004.
|
[7] |
ZENG F, CHEN B, ZENG J, et al. Preoperative neutrophil-lymphocyte ratio predicts the risk of microvascular invasion in hepatocellular carcinoma: A meta-analysis[J]. Int J Biol Markers, 2019, 34(3): 213-220. DOI: 10.1177/1724600819874487.
|
[8] |
NITTA H, ALLARD MA, SEBAGH M, et al. Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatic resection or liver transplantation[J]. Surgery, 2019, 165(6): 1168-1175. DOI: 10.1016/j.surg.2019.01.012.
|
[9] |
YANG GH, GAO ZL, SUN WJ, et al. The risk factors of microvascular invasion in hepatocellular carcinoma based on CT characteristics[J]. J Pract Radiol, 2020, 36(8): 1248-1252, 1265. DOI: 10.3969/j.issn.1002-1671.2020.08.018.
杨冠华, 高知玲, 孙文杰, 等. 基于CT特征肝细胞癌微血管侵犯危险因素研究[J]. 实用放射学杂志, 2020, 36(8): 1248-1252, 1265. DOI: 10.3969/j.issn.1002-1671.2020.08.018.
|
[10] |
BAI X, MA ZH, HAO ZQ, et al. Research advances in the risk factors for microvascular invasion in hepatocellular carcinoma[J]. J Clin Hepatol, 2019, 35(11): 2578-2581. DOI: 10.3969/j.issn.1001-5256.2019.11.042.
白雪, 马作红, 郝志强, 等. 肝细胞癌微血管侵犯相关危险因素[J]. 临床肝胆病杂志, 2019, 35(11): 2578-2581. DOI: 10.3969/j.issn.1001-5256.2019.11.042.
|
[11] |
ERSTAD DJ, TANABE KK. Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma[J]. Ann Surg Oncol, 2019, 26(5): 1474-1493. DOI: 10.1245/s10434-019-07227-9.
|
[12] |
SOTIROPOULOS GC, MACHAIRAS N, FOUZAS I, et al. Prediction of microvascular tumor invasion in liver transplant candidates with hepatocellular carcinoma: A feasible concept or a misleading illusion?[J]. Transplant Proc, 2019, 51(2): 421-423. DOI: 10.1016/j.transproceed.2019.01.016.
|
[13] |
AST V, KORDAβ T, OSWALD M, et al. MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion[J]. Oncotarget, 2018, 9(85): 35559-35580. DOI: 10.18632/oncotarget.26263.
|
[14] |
ZOU P, ZHU M, LIAN C, et al. miR-192-5p suppresses the progression of lung cancer bone metastasis by targeting TRIM44[J]. Sci Rep, 2019, 9(1): 19619. DOI: 10.1038/s41598-019-56018-5.
|
[15] |
ZHAO J, XU J, ZHANG R. SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt[J]. Am J Transl Res, 2018, 10(2): 483-490. http://europepmc.org/abstract/MED/29511442
|
[16] |
GU Y, WEI X, SUN Y, et al. miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features[J]. Cancer Res, 2019, 79(5): 941-953. DOI: 10.1158/0008-5472.CAN-18-1675.
|
[17] |
LI Y, ZHANG J, YAN LM. Values of miR-9, miR-192 and miR-205 in diagnosis of cervical cancer[J]. J Nanchang Univ(Med Sci Edition), 2020, 60(3): 74-77, 97. DOI: 10.13764/j.cnki.ncdm.2020.03.016.
李艳, 张锦, 闫丽明. miR-9、miR-192和miR-205在宫颈癌诊断中的价值[J]. 南昌大学学报(医学版), 2020, 60(3): 74-77, 97. DOI: 10.13764/j.cnki.ncdm.2020.03.016.
|
[18] |
DU X, QI F, LU S, et al. Nicotine upregulates FGFR3 and RB1 expression and promotes non-small cell lung cancer cell proliferation and epithelial-to-mesenchymal transition via downregulation of miR-99b and miR-192[J]. Biomed Pharmacother, 2018, 101: 656-662. DOI: 10.1016/j.biopha.2018.02.113.
|
[19] |
WANG XZ, WU WF. Correlation of the expressions of miR-155 and suppressor of cytokine signaling 1 mRNA in peripheral blood mononuclear cells with the degree of liver injury in patients with chronic hepatitis B[J/CD]. Chin J Liver Dis(Electronic Edition), 2019, 11(3): 14-20. DOI: 10.3969/j.issn.1674-7380.2019.03.003.
汪增秀, 吴卫锋. 慢性乙型肝炎患者外周血单个核细胞中miR-155和细胞因子信号转导抑制分子1相对表达量与肝功能损伤程度的相关性[J/CD]. 中国肝脏病杂志(电子版), 2019, 11(3): 14-20. DOI: 10.3969/j.issn.1674-7380.2019.03.003.
|
[20] |
SHAO MF, ZOU JA, YU ZQ, et al. Expression and clinical significance of miR-21 in peripheral blood mononuclear cells of patients with prostate cancer[J]. Chin J Med Offic, 2019, 47(8): 799-801, 803. DOI: 10.16680/j.1671-3826.2019.08.09.
邵明峰, 邹建安, 余子强, 等. 前列腺癌患者外周血单个核细胞中miR-21表达及临床意义[J]. 临床军医杂志, 2019, 47(8): 799-801, 803. DOI: 10.16680/j.1671-3826.2019.08.09.
|